OR YEHUDA, Israel, Oct. 24, 2013 /CNW/ - Valtech Cardio Ltd, a medical device company that develops solutions for mitral valve repair and replacement, announced today that 11 patients have been ...

Valtech Cardio, Ltd., (Valtech), an innovator in the development of devices for mitral and tricuspid valve repair and replacement, announced today it has received Conformite Europeenne (CE) Marking ...

IRVINE, Calif., Edwards Lifesciences Corporation, the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced that it has received CE ...

OR YEHUDA, Israel, Valtech Cardio, Ltd., an innovator in the development of surgical and transcatheter devices for mitral and tricuspid valve repair and replacement, announces planned activities at ...

Valtech Cardio Ltd., a medical device company that develops solutions for mitral valve repair and replacement, announced today that two patients diagnosed with severe mitral regurgitation (MR) have ...

Please provide your email address to receive an email when new articles are posted on . In patients with functional mitral regurgitation, use of a transcatheter annuloplasty system was effective and ...

LONDON, UK / ACCESSWIRE / November 29, 2016 / Active Wall St. blog coverage looks at the headline from Edwards Lifesciences Corp. (EW) as the company announced on November 28, 2016, that it has ...

OR YEHUDA, Israel, Sept. 14, 2015 /PRNewswire/ -- Valtech Cardio, Ltd., (Valtech), an innovator in the development of devices for mitral and tricuspid valve repair and replacement, announced today it ...

Valtech Cardio, a company out of Or Yehuda, Israel, has received European CE Mark to introduce its Cardioband annuloplasty system. According to the company, the Cardioband system is a revolutionary ...